Skip to content

Internet-delivered CBT for Insomnia: Role of Sleep-related Cognitions

Internet-delivered CBT for Insomnia: Role of Sleep-related Cognitions

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01955928
Enrollment
63
Registered
2013-10-08
Start date
2013-10-31
Completion date
2014-12-31
Last updated
2018-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Brief summary

The object of this study is to compare internet-delivered treatment for insomnia to a waiting-list. In this study participants are randomized to: 1) online cognitive-behavioral 2) waiting-list. Participants in the waiting-list condition receive treatment after the post-test. The interventions consist of: diary; psycho-education; relaxation exercises; stimulus control/sleep hygiene; sleep restriction; challenging the misconceptions about sleep; and paradoxical exercise. Adult persons with insomnia will be invited via a popular scientific website to fill out online questionnaires. Participants will fill out questionnaires and a dairy at baseline post-test, 3-month follow-up, and 6-month follow-up. In this study we are interested in sleep-related worry and daily complaints measured with a diary. We expect that the online intervention ameliorates both the sleep-related worry and the daily complaints. Furthermore, we expect that the sleep related worry mediates the effect of the intervention on sleep- and daily complaints.

Interventions

BEHAVIORALOnline Cognitive behavioral treatment for insomnia

Sponsors

VU University of Amsterdam
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Insomnia disorder according to DSM-5 * Sleep onset latency/wake after sleep onset \> 30 minutes , three times or more a week * Insomnia three months or longer * Access to internet

Exclusion criteria

* Earlier cognitive behavioral treatment for insomnia * Start other psychological treatment in the last 6 months * Doing shift work * Pregnancy or breast feeding * Schizophrenia or psychosis * Suicidal plans * Sleep apnea * drugs or alcohol abuse

Design outcomes

Primary

MeasureTime frameDescription
Daytime symptoms of sleep related worry measured with the APSQChange from baseline to post-test, 3-months, and 6-months follow-upDaytime symptoms of sleep related worry will be measured with a daily Anxiety and Pre-occupation about sleep questionnaire.
Daytime symptoms measured with diary consisting of the DASS-21Change from baseline to post-test, 3-months, and 6-months follow-upThe daytime symptoms will be measured with the 7 items of the stress scale of the DASS-21

Secondary

MeasureTime frameDescription
Sleep related safety behaviors measured with the SRBQChange from baseline to post-test, 3-months, and 6-months follow-up
Sleep related arousal measured with the Pre-arousal sleep scaleChange from baseline to post-test, 3-months, and 6-months follow-up
Sleep related worry measured with the Anxiety and Pre-occupation about Sleep ScaleChange from baseline to post-test, 3-months, and 6-months follow-up
Depression measured with the CES-DChange from baseline to post-test, 3-months, and 6-months follow-up
Sleep related cognitions measured with the Dysfunctional Beliefs and Attitudes about sleep scale (DBAS)Change from baseline to post-test, 3-months, and 6-months follow-up
Sleep medication usage per day measured with the sleep diaryChange from baseline to post-test, 3-months, and 6-months follow-up
sleep continuity (consisting of sleep latency, time awake after sleep onset, total sleep time)Change from baseline to post-test, 3-months, and 6-months follow-upSleep continuity is measured with a 7-day sleep diary based on the consensus sleep diary.
Repetitive thinking measured with the Dutch Perseverative Thinking QuestionnaireChange from baseline to post-test, 3-months, and 6-months follow-up
Anxiety measured with the HADS-AChange from baseline to post-test, 3-months, and 6-months follow-up

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026